MTI Ventures

Spectromics Limited is a diagnostic technology company based in Manchester, United Kingdom, founded in 2014. The company specializes in developing a point-of-prescription test designed to guide antibiotic treatment for bacterial infections. This innovative system detects bacterial susceptibility to drugs by analyzing the underlying metabolism of pathogens. By identifying antimicrobial susceptibility and resistance during patient appointments, Spectromics aims to assist healthcare professionals in eliminating ineffective empirical prescriptions, thereby providing targeted treatment recommendations for specific pathogens. This approach enhances the effectiveness of antibiotic treatment and contributes to improved patient outcomes.

Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.

Arago Technology Ltd. is a company based in Manchester, United Kingdom, that specializes in developing advanced composite technology for the electricity and power industry. Founded in 2010, Arago focuses on creating electrically insulating composite cross-arms for transmission towers, enabling the construction of smaller towers and the upgrading of existing structures to accommodate higher voltages. This innovative technology allows for increased tower voltages without altering the overall profile or height of the towers. By implementing this solution, Arago aims to support the National Grid and other global transmission companies in meeting the anticipated 50% increase in electrical energy demand, which is essential for the decarbonization of energy and the integration of electric vehicles and heat pumps by 2050. The company also provides consultancy and other related services, positioning itself as a key player in the evolution of power infrastructure.

PowerOasis Limited is a UK-based company that specializes in energy and critical infrastructure management solutions designed to enhance energy efficiency and infrastructure resilience. The company offers an Energy Management Platform, a comprehensive software suite that facilitates the Internet of Energy by enabling control, monitoring, and management of diverse energy generation, storage, and efficiency assets. This platform is customizable to meet the specific requirements of various licensees, including battery vendors and utilities. Additionally, PowerOasis develops and manufactures hybrid power systems, including a hybrid control cabinet, SolarCompact, and PowerCube, which integrate energy generation and storage solutions. The company's technology serves a wide range of sectors, including energy storage, transportation, oil and gas, and critical infrastructure, and it has established a presence in South East Asia, Africa, the Middle East, and North America. Founded in 2006 and headquartered in Swindon, PowerOasis aims to empower organizations to optimize their energy operations effectively.

Oxford PV is a company based in Oxford, United Kingdom, that specializes in the development and commercialization of thin-film perovskite solar cells. Founded in 2010 by Henry Snaith and Kevin Arthur, the company focuses on integrating these solar cells with traditional silicon solar cells, CIGS solar cells, or glass. Oxford PV's innovative technology enhances photovoltaic performance by effectively capturing specific parts of the solar spectrum, providing a low-cost, thin-film alternative for renewable energy generation. The company's mission supports the global transition to sustainable energy solutions.

Renephra Ltd. is a medical device company based in Manchester, United Kingdom, established in 2009. It specializes in developing innovative Transdermal Fluid Removal (TFR) technology aimed at addressing fluid overload and chronic conditions such as oedema and lymphoedema. The company's devices utilize a micro-needle system combined with negative pressure therapy to facilitate minimally invasive fluid removal from the skin. This technology targets significant clinical needs within vascular and oncology patients, representing a large and underserved market estimated at £1 billion globally. Having achieved proof of concept in human trials, Renephra is currently seeking funding to advance its device development and feasibility studies.

BiOxyDyn is a company focused on developing and applying innovative diagnostic imaging tools and services. Its technology portfolio aims to enhance the understanding of various diseases, particularly in the areas of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma, as well as oncology and neuroscience. By providing advanced imaging tools, BiOxyDyn enables physicians to monitor disease progression and evaluate the effects of treatments across a range of conditions, including neurological disorders and inflammatory diseases. This comprehensive approach facilitates accurate disease characterization, ultimately contributing to improved patient outcomes.

Arvia Technology Limited, established in 2007 and based in Runcorn, UK, specializes in water and wastewater treatment systems. The company's core product is the Organics Destruction Cell (ODC), a tertiary treatment system that combines adsorption and advanced oxidation to remove hard chemical oxygen demand, color, and persistent organic micro-pollutants from wastewater. The ODC uses Arvia's patented regenerating adsorbent, Nyex, to concentrate and continuously oxidize contaminants, ensuring water quality compliance with local discharge regulations or suitability for reuse. Serving industries such as chemicals, food and beverage, pharmaceuticals, and utilities, Arvia's technology offers a cost-effective, chemical-free, and low-maintenance solution for treating hazardous organic chemicals in water.

Ai2 Ltd is a biotechnology company based in Manchester, United Kingdom, established in 2004. The company specializes in the development of anti-infective peptide technology derived from the amino acid sequence of human protein Apo lipoprotein E. These peptides demonstrate broad-spectrum efficacy against various pathogens, including Gram-positive and Gram-negative bacteria, fungi, and viruses, including resistant strains. Ai2's technology has diverse applications in healthcare and personal care, encompassing ophthalmic products, oral care, advanced wound care, and medical devices. The company produces coated hydrogels, artificial joints, endotracheal tubes, wound dressings, and urinary and vascular catheters designed to prevent microbial colonization and contamination. Ai2 serves healthcare companies primarily in the United States and Europe, enabling medical practitioners to utilize its innovative technology across multiple applications.

PowerOasis Limited is a UK-based company that specializes in energy and critical infrastructure management solutions designed to enhance energy efficiency and infrastructure resilience. The company offers an Energy Management Platform, a comprehensive software suite that facilitates the Internet of Energy by enabling control, monitoring, and management of diverse energy generation, storage, and efficiency assets. This platform is customizable to meet the specific requirements of various licensees, including battery vendors and utilities. Additionally, PowerOasis develops and manufactures hybrid power systems, including a hybrid control cabinet, SolarCompact, and PowerCube, which integrate energy generation and storage solutions. The company's technology serves a wide range of sectors, including energy storage, transportation, oil and gas, and critical infrastructure, and it has established a presence in South East Asia, Africa, the Middle East, and North America. Founded in 2006 and headquartered in Swindon, PowerOasis aims to empower organizations to optimize their energy operations effectively.

Oxford PV is a company based in Oxford, United Kingdom, that specializes in the development and commercialization of thin-film perovskite solar cells. Founded in 2010 by Henry Snaith and Kevin Arthur, the company focuses on integrating these solar cells with traditional silicon solar cells, CIGS solar cells, or glass. Oxford PV's innovative technology enhances photovoltaic performance by effectively capturing specific parts of the solar spectrum, providing a low-cost, thin-film alternative for renewable energy generation. The company's mission supports the global transition to sustainable energy solutions.

Eykona Medical develops and markets portable three dimensional imaging systems. Its systems are used to capture environments for videogames and in medical imaging for dermatological care. The company is based in Oxford, the United Kingdom.

BiOxyDyn is a company focused on developing and applying innovative diagnostic imaging tools and services. Its technology portfolio aims to enhance the understanding of various diseases, particularly in the areas of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma, as well as oncology and neuroscience. By providing advanced imaging tools, BiOxyDyn enables physicians to monitor disease progression and evaluate the effects of treatments across a range of conditions, including neurological disorders and inflammatory diseases. This comprehensive approach facilitates accurate disease characterization, ultimately contributing to improved patient outcomes.

Ai2 Ltd is a biotechnology company based in Manchester, United Kingdom, established in 2004. The company specializes in the development of anti-infective peptide technology derived from the amino acid sequence of human protein Apo lipoprotein E. These peptides demonstrate broad-spectrum efficacy against various pathogens, including Gram-positive and Gram-negative bacteria, fungi, and viruses, including resistant strains. Ai2's technology has diverse applications in healthcare and personal care, encompassing ophthalmic products, oral care, advanced wound care, and medical devices. The company produces coated hydrogels, artificial joints, endotracheal tubes, wound dressings, and urinary and vascular catheters designed to prevent microbial colonization and contamination. Ai2 serves healthcare companies primarily in the United States and Europe, enabling medical practitioners to utilize its innovative technology across multiple applications.

Exosect Limited, established in 2001 as a spin-out from the University of Southampton, specializes in developing innovative platforms that enhance the delivery of biological and synthetic active ingredients for pesticide manufacturers. The company's proprietary technologies, including the Entostat and Entomag delivery platforms, address challenges such as pest resistance, regulatory compliance, and food safety residues. The Entostat platform utilizes an electrostatically charged micro powder for microencapsulation and controlled release of active ingredients, while the Entomag platform employs ferrous micro powder for targeted delivery, particularly against crawling insects in public health applications. With a robust portfolio of 41 patents and 28 national product registrations, Exosect is strategically positioned to commercialize its patented technologies across agriculture, public health, and animal health sectors, aiming to improve pest control and food protection. The company is headquartered in Winchester, United Kingdom.

Nano ePrint, Ltd. develops electronic devices. Its products are used in printed and plastic electronics applications, including radio-frequency identification, sensors, and display backplanes. The company also provides intellectual property licences, as well as research, development, and supply chain support services. Nano ePrint, Ltd., formerly known as Plastic ePrint Limited, was founded in 2006. The company is based in Manchester, the United Kingdom.

Lein Applied Diagnostics Ltd. is a company focused on developing innovative measurement devices and solutions for the healthcare and industrial sectors. Founded in 2003 and based in Reading, United Kingdom, Lein specializes in optical metrology and non-invasive measurement technology. Its product lineup includes the Dione source/detector module for multi-layer thickness measurements, the compact Icon system for optical measurement of various materials, the fScan non-contact 3D fluorescence tracking plate reader for real-time measurements, and the CTS2 system for measuring the thickness of 3D engineered tissues and cells. These products cater to applications in metrology, pharmacokinetics, and diabetes care. Lein sells its solutions through agents in China, Japan, and North America, leveraging a strong suite of patents and a highly qualified engineering team to address complex measurement challenges in both organic and man-made materials.

Datalase Ltd. specializes in developing materials for laser coding and marking across various industries, including pharmaceuticals, food and beverage, electronics, cosmetics, and tobacco. The company's innovative ink solutions enable high-speed, in-line digital printing, allowing for the customization of packaging with variable information such as date and lot codes, barcodes, and graphics. Datalase's proprietary technology is designed for use on outercases, products, and primary packaging, enhancing quality and operational efficiency for brand owners. The company operates through a partner network in Europe, the United States, and Asia, and has established strategic partnerships with key industry players. Founded in 1987 and based in Widnes, United Kingdom, Datalase was previously known as Sherwood Technology Ltd. before rebranding in 2006.

Eleksen Group designs and develops fabric touchpads for use in human machine interface design using its ElekTex technology. The company licenses ElekTex and reference design to manufacturers for use in custom electronics design, as well as markets a range of ready-to-integrate solutions for garment, bags, and accessories manufacturers. It offers sensors for use in soft-goods products, such as apparel and accessory products, as well as in other applications to provide control interfaces.

Global Silicon Limited, a fabless semiconductor company, engages in the design, development, and manufacture of proprietary mixed signal chips for the consumer audio market. It offers CD servo controllers and high performance MP3 and windows media audio (WMA) decoders. The company also offers PCB modules, design wins, and xin servo/mp3/wma. Global Silicon Limited was formerly known as Cheap and Cheerful Chip Company Limited. The company was incorporated in 1997 and is based in Marlow, the United Kingdom with additional offices in Fenggang, Swavesey, and Cambridge, as well as in Shenzhen, the People's Republic of China. Global Silicon Limited is in receivership.

Medisyn Technologies, Inc. is a biotechnology company based in Minnetonka, Minnesota, that specializes in the development of proprietary drug compounds aimed at treating various forms of cancer, including breast, renal, prostate, and lung cancer. Utilizing its Forward Engineering platform, the company creates pre-qualified compounds and also focuses on analyzing and optimizing existing drugs as well as developing new candidates in collaboration with partners. Additionally, Medisyn offers testing and analysis services to assess the safety and efficacy of its compounds. Beyond cancer treatments, the company is engaged in discovering bioactive drug compounds for infectious diseases and Alzheimer's disease, ultimately aiming to expedite patient treatment and improve success rates. Founded in 1999, Medisyn Technologies serves the biotechnology and pharmaceutical sectors.

Andritz Powerlase Ltd. specializes in the design and manufacture of high-power pulsed lasers tailored for industrial applications, particularly in materials processing. The company provides a range of laser types, including infrared, green, and ultraviolet lasers, which are utilized in various processes such as surface polishing, rust removal, de-painting, laser annealing, and cleaning. Established in 2000 and based in Crawley, United Kingdom, Andritz Powerlase has developed significant expertise in creating advanced solutions for diverse markets, including automotive, aerospace, and defense. The company's technology enables efficient processing for applications like flat panel displays, photovoltaic systems, and microelectronics. Formerly known as Powerlase Photonics Limited, it rebranded in June 2017 and operates as a subsidiary of Andritz AG.

Beach Solutions, founded in 1998, specializes in providing software services tailored for the semiconductor industry. The company has developed expertise in system-on-chip Internet protocol packaging, deployment, and system integration software products, catering to developers of embedded systems. With a team that boasts over 200 man-years of experience in embedded systems engineering, Beach Solutions has a strong foundation in designing 32-bit RISC devices and systems. Their capabilities include real-time systems, VHDL and RTL coding, as well as application code development in C and assembler languages, supported by tool development across both UNIX and PC platforms. The three founding members continue to play active roles as executive board members of the company.

ApaTech Ltd. is an ortho-biologics company based in Elstree, United Kingdom, specializing in synthetic bone repair materials for surgical applications. Founded in 2001, the company develops innovative products such as Actifuse, a synthetic bone graft that enhances bone formation and is particularly effective for small void filling and spinal fusion. Additionally, ApaTech offers ApaPore, a porous hydroxyapatite grafting solution designed for the revision of failed total joint arthroplasties and the treatment of bone defects. The Actifuse MIS Bone Graft Delivery System provides precise delivery and placement for a range of surgical procedures, including open and minimally invasive operations. ApaTech distributes its products through a network of partners across multiple countries, including those in Europe and Australia. The company also maintains operations in London, Foxborough, Massachusetts, and Berlin, Germany.

Sarantel specializes in the design and manufacture of high-performance miniature antennas tailored for portable wireless applications. The company's innovative ceramic filtering antennas significantly enhance performance compared to traditional designs, resulting in clearer signals, improved range, and a substantial reduction in the signal radiation absorbed by the human body. The compact size and advanced capabilities of Sarantel's antennas empower manufacturers to develop cutting-edge wireless products across various markets, including GPS, satellite radio, and satellite phone technologies.

DCT develops, licences and manufactures semiconductor IP, integrated circuits, software and development systems. Founded with personal investments from Turner & Kubiczek, it went on to win a Small Firms Merit Award for Research & Technology from the UK Department of Trade & Industry award for its novel and world-leading performance embedded Java CPU Lightfoot. Following the UK DTI investment, DCT closed two funding rounds with MTI, a global, early-stage Venture Capital investor and set up offices in California and Taiwan. DCT also developed the Bigfoot Java Accelerator IP that found application in video processor ICs. The company was incorporated in 1996 and is currently based in Egham, UK and Shanghai, China. It is presently developing an exciting new version of its Lightfoot architecture, LF v3, that will deliver new performance levels to resource-limited embedded ASSPs.

A provider of enterprise monitoring and data collection software